Hadasit is participating in HUJIpulse's Year-Opening Event on discovering how AI is leading the revolution in science and medicine. Register here: https://heyor.ca/iwl0LG What’s on the agenda? ✨ Dr. Yair Benita, CTO of AION Labs, will kick off with a fascinating overview of AI’s impact on the world of biomedicine. ✨ Dr. Lior Nissim, a synthetic biology expert from The Hebrew University of Jerusalem, will share how AI is advancing his groundbreaking research. ✨ Prof. Shai Rosenberg, senior Neuro-Oncologist and Head of the Computational Biology of Cancer at Hadassah Medical Center, will demonstrate how algorithms developed in the hospital setting are paving its way to the industry applications. When and Where? Monday, December 23, at 6:00 PM 📍 Medical Library, Ein Kerem Campus, The Hebrew University of Jerusalem Why Should You Join? 🌟 Get inspired by top experts in the field. 🌟 Discover cutting-edge tools in artificial intelligence. 🌟 Connect with people shaping the future of medical innovation. #AIInMedicine #AIResearch #MedicalInnovation Yissum, The Hebrew University Tech Transfer Company | AION Labs | ASPER-HUJI Innovate
Hadasit Medical Research Services & Development
Biotechnology Research
Jerusalem עוקבים, Israel 5,489
We are the technology transfer company and innovation engine of #Hadassah Medical Center @Jerusalem
עלינו
Hadasit, the innovation engine of Hadassah Medical Center in Jerusalem, is the doorway to Hadassah technologies and research excellence. We transform cutting-edge research into marketable medical technologies, improving human health, and changing the world for the better. Hadasit works alongside Hadassah researchers in the fields of pharmaceuticals, molecular diagnostics, medical device, life science, biotech, and digital health. Our role: 📌 Hadasit identifies, protects, nurtures and commercializes the diverse innovations made at Hadassah Medical Center. 📌 Hadasit invests in start-up companies, licenses technologies, and collaborates with leading international companies, institutions and research facilities. 📌 Provide companies with R&D services and preclinical studies performed with the scientific and technological excellence at Hadassah Medical center laboratories To date, Hadasit has helped establish over 70 companies, including Hadasit Bio-Holdings (TASE: HDST), Oramed Pharmaceuticals Inc. (NASDAQ: ORMP), Immuron (ASX: IMC), Insuline Medical (INSL.TA), CardioVia, SynCath NeuroScience, eDAS Healthcare, Cell Cure Neurosciences, Exalenz Bioscience, Enlivex Pharmaceuticals, KAHR Medical, Brainstorm (NASDAQ: BCLI), Akashi Therapeutics, PamBio, Fidmi Medical, GuideIn Medical, Cordio Medical, Granalix, Swift-Duct, Nobio, BrainWatch Tech and more. Specific fields of expertise include Oncology, Immunotherapy, Cell therapy, Drug discovery, Drug development, Personalized medicine, Artificial Intelligence in the Pharmaceutical industry, Molecular diagnostics, Ophthalmology, Cardiology, Microbiology, Virology, Pulmonology and Dentistry. Hadasit's major driver is making a robust impact on healthcare by building optimum partnerships between academy and industry.
- אתר אינטרנט
-
http://www.hadasit.org.il
קישור חיצוני עבור Hadasit Medical Research Services & Development
- תעשייה
- Biotechnology Research
- גודל החברה
- 11-50 עובדים
- משרדים ראשיים
- Jerusalem, Israel
- סוג
- בבעלות פרטית
- הקמה
- 1986
מיקומים
-
הראשי
Hadassah Ein Kerem POB 12000
Jerusalem, Israel 91120, IL
עובדים ב- Hadasit Medical Research Services & Development
עדכונים
-
🚀🚀🚀 We’re excited to introduce #HepaCure #Pharma, our newest spinout company developed from the groundbreaking research of Prof. Rifaat Safadi and his team member Dr. Johnny Amer at the Hadassah Medical Center Liver Institute joining NGT portfolio. https://lnkd.in/d7aCvnRM #HepaCure #Pharma is pioneering a first-in-class peptide therapy uniquely targeting both immune and fibrotic cells to tackle #NAFLD (Non-Alcoholic Fatty Liver Disease)—a condition expected to impact over 25% of the global population by 2030. NAFLD, which can progress to severe conditions such as fibrosis, cirrhosis, and even non-curable carcinoma, has long lacked effective treatment options. We are incredibly grateful to our partners at NGT and the Israel Innovation Authority רשות החדשנות I for their unwavering support of the innovation emerging from Hadassah hospitals. Wishing Dr. Shmuel Klang, CEO of HepaCure Pharma, every success on this exciting journey 💡 #NAFLD #PrecisionMedicine #Innovation #Hadasit #Hadassah #Biotech #LiverHealth #IsraeliInnovationAuthority Israel Innovation Authority רשות החדשנות Tamar Raz Nadav Askari, Ph.D. Zohar Gendler Livnat Ben-Zur Adriana Folberg-Blum
-
✨ What an incredible day at the Pathology & Precision Medicine Conference it was! ✨ The energy in the room was palpable—we even had to bring in more chairs to accommodate everyone! 🙌 A huge thanks to all our amazing speakers who made this event so impactful: 💡 Dr. Tzahi Neuman 💡Prof. Dr. Yaniv Sherer- MD, MHA 💡 Prof. eli pikarsky 💡 Tuvik Beker, Pangea Biomed 💡 Olga Nissan, Protica Bio 💡 Prof. Dror Mevorach 💡 Dr. Nir Pillar 💡 Masha Zavin 💡 Dorit Tzur From discussions on pathology multimodalities to the latest advancements in precision cancer medicine, the insights shared were both thought-provoking and inspiring. The conference was not only a testament to the strength of Hadassah Medical Center and Hadasit's current partnerships but also an exciting opportunity to connect with new potential collaborators. 🌟 We are deeply grateful to everyone who attended and contributed to the vibrant atmosphere. 👉 Explore more about the Pathology Department and feel free to reach out—we’re always looking forward to fostering new collaborations: https://lnkd.in/dU83DZk9 Here’s to advancing biomed industry and making a real impact, together! 🚀 #Pathology #PrecisionMedicine #Collaboration #Innovation Tamar Raz Sarah Kimhi Nadav Askari, Ph.D. Ariel Shrem Olga Firger Dorit Shemesh, PhD Kinneret Misgav, PhD Chaim Lotan Michal Lotem
-
+7
-
Countdown of 5 days before the #Pathology & #Precision #Medicine Conference. Do not miss an opportunity to hear the talk of Prof. Dror Mevorach, Chairman of the Helsinki Committee of the Hadassah Medical Center, who shall delve into ethical aspects of research involving human samples and data. Learning the nitty gritty of the regulatory process saves valuable time in the companies' R&D timeline! Last spots available: https://lnkd.in/dHyAaDiG Tzahi Neuman Tamar Raz
-
Israel Hayom ישראל היום: "PathKeeper" helped the surgeons at Hadassah Medical Center Ein Kerem to remove a dangerous cancerous tumor in the boy's spine - in just four hours. After the surgery, the boy recovered quickly and was released - straight to his brother's Bar Mitzvah celebration". What a joy and pride it is to us to see this outstanding technology developed through long time collaboration between Erez Lampert, the founder and CEO of PathKeeper and Dr. Josh Schroeder changing the outcomes for the patients! Bring on more news like that!
חדשנות רפואית מצילת חיים בהדסה עין כרם. 🔬 בזכות PathKeeper, מערכת הניווט המתקדמת בפיתוח כחול-לבן, הצליחו המנתחים בהדסה להסיר גידול מסוכן מעמוד השדרה של נער בן 16 – בתוך ארבע שעות בלבד. PathKeeper היא מערכת חדשנית, פרי פיתוחם של פרופסור Josh Schroeder, מנהל היחידה לניתוחי עמוד שדרה בהדסה ושל שותפו, Erez Lampert, מומחה בתחום ההדמיה הרפואית התלת-ממדית ובעל ניסיון רב במחקר ובפיתוח. 💡 המערכת מבוססת על מצלמה תלת-ממדית וטכנולוגיות הדמיה פורצות דרך, מאפשרת דיוק מירבי במהלך הניתוח וממזערת סיכונים. ✨ התוצאה? הנער התאושש במהירות והשתחרר מבית החולים בזמן לחגוג את בר המצווה של אחיו. זה לא רק הישג טכנולוגי – זו פריצת דרך שמצילה חיים. קראו עוד על הניתוח ועל המערכת שמובילה מהפכה עולמית >>
-
📢 Excited to introduce Olga Nissan, CEO of Protica Bio, who will be joining us on 25.11.24 to share insights on integration of advanced proteomics with machine learning utilizing human samples and data, empowering clinical decision-making in immunotherapy! Their proprietary platform, crafted by a renowned mass spectrometry expert from the Weizmann Institute of Science, enables breakthrough predictions in patient response and novel therapeutic development. Click this link to see full agenda and register https://lnkd.in/dHyAaDiG
-
Today, on #AliyahDay in Israel, we’re incredibly proud to celebrate our Director of IP, Adriana Folberg-Blum, who has been honored by the Ministry of Aliyah and Integration for her impactful contributions to Israel’s wellbeing during the war! Adriana was recognized by President Itzhak Herzog and peers, alongside four other exceptional individuals from diverse fields, including science, medicine, technology, agriculture and essential services. Just a week after October 7, Adriana and a few colleagues traveled south to assist farmers struggling to harvest during one of the most challenging periods, as much of their workforce had departed. Adriana’s initiative quickly grew—soon, nearly 1,500 volunteers joined her cause, in the group called “Thursday’s harvesters' bus”. She organized free buses to transport dozens of volunteers each Thursday, supporting over 20 different farms in the South of Israel - an effort that has continued for more than a year and remains active today. We couldn’t be prouder of Adriana and salute all the amazing volunteers who have joined her, giving their time and heart to support Israel’s agricultural community. Although Adriana made her Aliyah two decades ago, this recognition as an "Ola" is a testament to her enduring dedication to and belief in the “project” of Israel! Thank you, Adriana, and to everyone who stands with you! We hope that safer days will come, and our hostages, soldiers and citizens will be finally back home! 🎗️🎗️🎗️ (LinkedIn deleted yellow ribbon option 😠) Tamar Raz Nadav Askari, Ph.D. Ariel Shrem Masha Zavin Aviv Reisfeld Carole Grumbach Sarah Kimhi
-
+3
-
On 25.11.24 Dr. Tuvik Beker, CEO of Pangea Biomed shall join lineup of seasoned speakers with his talk about high-throughput genomic sequencing and digital pathology enhancing precision medicine in oncology. Pangea Biomed excels in promoting synergistic academia-industry collaborations and Tuvik shall share valuable insights with the audience about their journey. Click here for details and registration: https://lnkd.in/dHyAaDiG Tzahi Neuman Olga Firger Aron Popovtzer eli pikarsky Nadav Askari, Ph.D.
-
Introducing Dr. Nir Pillar, senior pathologist at Hadassah Medical Center, specializing in AI applications in pathology. With an MD from Ben-Gurion University and a PhD from Tel Aviv University, Dr. Pillar joined UCLA's Faculty of Engineering to focus on virtual histological staining using generative AI. In his talk, he will explore the concept of virtual staining, its necessity, and its transformative applications in pathology. Do not miss that: Click here for details and registration: https://lnkd.in/dHyAaDiG Tzahi Neuman
-
We are back to remind: Pathology and Precision Medicince conference & dinner is on 🔉 25.11.24 This special event organised by Hadassah Medical Center Pathology Department and Hadasit with support of BIOHOUSE GROUP will gather various industry stakeholders to uncover how #Pathology fuels biotech innovation and bridges the gap to #Precision #Medicine. Meet our first speaker Dr. Tzahi Neuman, Head of the Pathology department. Click this link to see full agenda and register: https://lnkd.in/dHyAaDiG Tamar Raz Nadav Askari, Ph.D. Adriana Folberg-Blum Olga Firger